---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-032352"
form_type: "8-K"
ticker: "SXTP"
cik: "0001946563"
company_name: "60 DEGREES PHARMACEUTICALS, INC."
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:31:20.928507+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# 60 Degrees Pharmaceuticals corrects beneficial ownership disclosure in March 13 prospectus

## Summary
- March 13 prospectus supplement incorrectly reported affiliate's beneficial ownership as 21,490 shares; correct is 23,367.
- Error originated from a September 2025 Form 4 and propagated through subsequent filings.
- Post-1-for-4 reverse split, corrected affiliate ownership is 16,781 shares vs previously reported 15,905.
- No other information in the March 13 prospectus supplement is affected by this correction.

## SEC filing metadata
- accession: 0001213900-26-032352
- form_type: 8-K
- ticker: SXTP
- cik: 0001946563
- company_name: 60 DEGREES PHARMACEUTICALS, INC.
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1946563/000121390026032352/0001213900-26-032352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1946563/000121390026032352/ea0282850-8k_60degrees.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-032352
- JSON: https://secwatch.observer/filing/0001213900-26-032352.json
- Plain text: https://secwatch.observer/filing/0001213900-26-032352.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
